Fulgent Genetics (FLGT) Non-Current Debt (2021 - 2026)

Fulgent Genetics (FLGT) has 6 years of Non-Current Debt data on file, last reported at $1.5 million in Q1 2026.

• Quarterly Non-Current Debt fell 24.62% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 24.62% YoY) and the FY2025 annual result came in at $2.0 million, down 21.46% from the prior year.
• Non-Current Debt fell to $1.5 million in Q1 2026 per FLGT's latest filing, from $2.0 million in the prior quarter.
• The five-year high for Non-Current Debt was $3.4 million in Q4 2022, with the low at $1.5 million in Q1 2026.
• Average Non-Current Debt over 5 years is $2.3 million, with a median of $2.5 million recorded in 2024.
• Year-over-year, Non-Current Debt slipped 12.1% in 2023 and declined 24.62% in 2026.
• Fulgent Genetics' Non-Current Debt stood at $3.4 million in 2022, then fell by 12.1% to $3.0 million in 2023, then declined by 15.89% to $2.5 million in 2024, then declined by 21.46% to $2.0 million in 2025, then decreased by 24.62% to $1.5 million in 2026.
• Business Quant data shows FLGT's Non-Current Debt at $1.5 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.